We acquired the Rochester, New York site in October 2013 to bring our innovative, affordable, and convenient delivery systems to the North American market. A major capital first phase investment of $16 million was used to install sterile Blow-Fill-Seal (BFS) and Liquid Unistick® capacity at the site.
The US market is primed for these novel unit dose solutions. Patients with active lifestyles, children, and seniors will benefit from premeasured, portable, and easy-to-use medicines. Our liquid Unistick system is currently in operation, and BFS will be qualified by the middle of 2016. We are currently evaluating a phase two project to add additional capacity.